Holen Sie sich die Stockscreener-App
0.495
1.39%
-0.007
Handel nachbörslich:
.50
0.005
+1.01%
Schlusskurs vom Vortag:
$0.502
Offen:
$0.5111
24-Stunden-Volumen:
700.00K
Relative Volume:
0.12
Marktkapitalisierung:
$17.38M
Einnahmen:
$2.91M
Nettoeinkommen (Verlust:
$-27.06M
KGV:
-0.3781
EPS:
-1.3092
Netto-Cashflow:
$-4.33M
1W Leistung:
-2.92%
1M Leistung:
-28.57%
6M Leistung:
-27.10%
1J Leistung:
-57.33%
1-Tages-Spanne:
$0.495
$0.5246
1-Wochen-Bereich:
$0.4812
$0.53
52-Wochen-Spanne:
$0.3803
$1.79
Osr Holdings Inc Stock (OSRH) Company Profile
Firmenname
Osr Holdings Inc
Sektor
Branche
Telefon
425-635-7700
Adresse
10900 NE 4TH STREET, SUITE 2300, BELLEVUE
Compare OSRH vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OSRH
Osr Holdings Inc
|
0.495 | 17.62M | 2.91M | -27.06M | -4.33M | -1.3092 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Osr Holdings Inc Aktie (OSRH) Neueste Nachrichten
OSR appoints Andreas Niethammer as Chief Medical Officer of Vaximm AG - MSN
OSR Holdings Q4 2025 Earnings: EPS Misses Estimates Amidst Weak Market SentimentEBITDA Margin Trends - Newser
OSR Holdings (OSRH) Q4 2025 Earnings: Miss Sparks ConcernDownward Estimate Revision - Newser
OSR Holdings (OSRH) Falls -1.94% — Watching $0.47 Support 2026-05-20Straddle Setup - Newser
Should You Sell OSR Holdings (OSRH) After -8.25% Drop? 2026-05-18High Interest Stocks - Newser
OSR Holdings stock surges over 41% after hours: Why is it moving? - MSN
OSRH - Finviz
Number of shareholders of OSR Holdings, Inc. – NASDAQ:OSRH - TradingView
TradingKey - TradingKey
OSR Holdings, Inc. Q1 2026 Financial Report: Business Combination, Subsidiary Overview, and Key Financial Results - Minichart
OSR Holdings, Inc. 1Q 2026: Revenue $484.1K, EPS $(0.08) — 10-Q Summary - TradingView
OSR Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[10-Q] OSR Holdings, Inc. Quarterly Earnings Report - Stock Titan
OSR Holdings rules out reverse stock split amid Nasdaq compliance efforts - Investing.com
CEO Statement to Shareholders - marketscreener.com
About Us | Cabling Installation & MaintenanceCEO Statement to Shareholders - FinancialContent
OSR Holdings (OSRH) seeks approval to raise equity plan to 8.0M shares, name change - Stock Titan
How OSR Holdings (OSRH) geographic mix shifted this quarter | Q4 2025: EPS Misses EstimatesSocial Buzz Stocks - newser.com
Why OSR (OSRHW) ability to generate cash matters (Soars) 2026-05-08Growth Factor - Newser
OSR Holdings–BCM Europe VXM01 Global License Deal: Avance Fairness Opinion Confirms Financial Terms Are Fair for Shareholders - Minichart
The edge OSR (OSRHW) has in a competitive landscape (Skyrockets) 2026-05-06Trending Stock Ideas - newser.com
OSR Holdings (NASDAQ: OSRH) gets fairness view on $815M VXM01 deal - Stock Titan
Emerging Growth Research Issues Flash Report on OSR Holdings, Reaffirms Buy-Emerging Rating and $10.00 Price Target - Scott Coop
OSRH stock rockets 60% on $815M immunotherapy deal — retail bulls eye $1 mark for the stock - MSN
OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026 - Black Hills Pioneer
OSRH Stock Price, Quote & Chart | OSR HOLDINGS INC (NASDAQ:OSRH) - ChartMill
OSRH Rockets 60% On $815M Immunotherapy Deal — Retail Bulls Eye $1 Mark For The Stock - Stocktwits
These stocks are moving in today's session - ChartMill
Check out the stocks that are attracting the most attention and driving market activity. - ChartMill
OSR Holdings Grants BCME Exclusive Global VXM01 Rights - TipRanks
BCM Europe pledges 29.7% OSR Holdings (NASDAQ: OSRH) stake in $815M VXM01 deal - Stock Titan
OSR Holdings to explain its VXM01 licensing deal in May 7 webcast - Stock Titan
OSR Holdings Stock Surges Over 41% After Hours: Why Is It Moving?OSR Holdings (NASDAQ:OSRH) - Benzinga
OSR Holdings (OSRH) Stock: Direction Change Signals | Q4 2025: Earnings Fall ShortFloat Short - Newser
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
What's going on in today's after hours session - ChartMill
Wednesday's session: top gainers and losers - ChartMill
OSR Holdings licenses VXM01 to BCME for up to $815M in milestones By Investing.com - Investing.com South Africa
OSR Holdings licenses VXM01 to BCME for up to $815M in milestones - Investing.com Australia
OSR Holdings Announces $815M License Agreement for VXM01 - ACCESS Newswire
OSR Holdings Executes Definitive $815 Million Global License Agreement for VXM01 with BCM Europe - newswire.com
Top shareholder pledges 29.7% stake behind OSR Holdings' $815M drug deal - Stock Titan
Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target - The Florida Times-Union
OSR Holdings Appoints Yeiseok Kim as Chief Operating Officer Effective April 16, 2026 7 - Minichart
Finanzdaten der Osr Holdings Inc-Aktie (OSRH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):